Co-immunoprecipitation

NA Nadine D. Arnold
JP Josephine A. Pickworth
LW Laura E. West
SD Sarah Dawson
JC Joana A. Carvalho
HC Helen Casbolt
AB Adam T. Braithwaite
JI James Iremonger
LR Lewis Renshall
VG Volker Germaschewski
MM Matthew McCourt
PB Philip Bland-Ward
HK Hager Kowash
AH Abdul G. Hameed
AR Alexander M. K. Rothman
MF Maria G. Frid
AT A. A. Roger Thompson
HE Holly R. Evans
MS Mark Southwood
NM Nicholas W. Morrell
DC David C. Crossman
MW Moira K. B. Whyte
KS Kurt R. Stenmark
CN Christopher M. Newman
DK David G. Kiely
SF Sheila E. Francis
AL Allan Lawrie
request Request a Protocol
ask Ask a question
Favorite

PASMCs were stimulated with rhOPG (500 ng ml−1) for 30 min at 37 °C. After stimulation, cells were lysed and the protein lysate concentration determined by a Pierce 660 nm protein assay. Co-immunoprecipitation was then performed using an anti-Fas or Ky3 antibody with human PASMC lysate and recombinant proteins, alongside negative controls, where antibodies were not added. ProteinG sepharose 4 Fast Flow beads (50% slurry) were added to each Co-IP reaction and immune complexes were precipitated. Each Co-IP reaction was then centrifuged and the pellet washed before re-suspending in sample reducing agent (NuPAGE, Life Sciences) with 5% v/v SDS and heating at 95°C. The supernatant was then analysed by western blotting. Membranes were incubated with goat polyclonal anti-OPG antibody (1:1000) (SC8468, Santa Cruz Biotechnology) or anti-Fas antibody (MA1–7622, Invitrogen) and IRDye 680LT Donkey anti-goat secondary antibody (1:15000) or IRDye 800CW donkey anti-mouse secondary antibody (1:15000) (Li-COR) to detect co-immunoprecipitated OPG. Membranes were scanned using the Li-COR Odyssey Sa system (LiCOR).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A